Colombian Congress of Vascular Surgery and Angiology 2018

GBT sponsored the XXII Colombian Congress of Vascular Surgery and Angiology 2018.

Montevideo, Uruguay March 10, 2018. GBT sponsored the XXII Colombian Congress of Vascular Surgery and Angiology 2018 (http://www.asovascular.com/) that took place between March 7 and 10 in the city of Barranquilla, Colombia.

GBT and its commercial partner for ALPROSTAPINT®, Pint Pharma, sponsored the participation of two outstanding academics as part of its continuing medical education program with the aim of creating awareness about Peripheral Arterial Disease and presenting recently published bibliography:

Dr. Helmut Sinzinger (Austria) spoke about PGE1 in peripheral arterial disease, with a critical approach for evidence-based medicine.

Dr. Jorge Machado (Colombia) presented about the experience in Colombia of the use of ALPROSTAPINT®, with Critical limb ischemia.

The event convened and had the participation of more than 400 attendees, mainly Colombian and foreign vascular surgeons, with the participation of invited foreign professors from the Netherlands, Portugal, USA, Argentina, Mexico and Brazil.

About Alprostapint® (Alprostadil)
Alprostadil is a prostaglandin E1 whose hemodynamic properties and antiplatelet action support its use in the treatment of severe peripheral vascular disease. Alprostapint® 20μg is indicated in the treatment of Peripheral Arterial Occlusive Disease of Fontaine III and IV when an alternative treatment is not possible or it has been ineffective.

Media requests

If you are a member of the press, please send a question to our Corporate Affairs team here.

Click here

Press Releases

To access all Press Releases published by GBT, click here.